Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-24-045321
Filing Date
2024-11-14
Accepted
2024-11-14 06:45:09
Documents
1
Effectiveness Date
2024-11-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8855
  Complete submission text file 0001493152-24-045321.txt   10354
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-529370 | Film No.: 241457002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)